Global Wealth Management Investment Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Global Wealth Management Investment Advisory's AZN Position: Q1 2024 in Review
Global Wealth Management Investment Advisory sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 20 shares — an estimated $2.63K sold.
Global Wealth Management Investment Advisory first reported a position in AZN in Q4 2018 and held it in 18 quarters. The position peaked at $1.99M in Q4 2019. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.
- Global Wealth Management Investment Advisory reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
- Global Wealth Management Investment Advisory sold 20 AstraZeneca shares in Q1 2024, an estimated $2.63K.
- Global Wealth Management Investment Advisory first reported a position in AstraZeneca in Q4 2018 and held it in 18 quarters.
- Global Wealth Management Investment Advisory's AstraZeneca position peaked at $1.99M in Q4 2019.
- 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.
Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.